WHO Issues Warning Over Acute Scarcity of Obesity Injections
Fewer than a tenth of individuals that would benefit from obesity jabs including Wegovy can access them, caution the World Health Organization as it releases its inaugural guidance on the medications.
With more than one billion people worldwide now classified as obese, it is calling for more widespread and fairer access to these injectable treatments.
Based on forecasts, in excess of 2,000,000,000 could be obese by 2030 if no action is taken.
"The new guidance affirms that excess weight is a long-term condition that can be managed with holistic and ongoing care," remarked WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and distribution challenges are significant obstacles to universal availability to the injections that can aid individuals in losing considerable body mass, says the body.
Skinny Jab Scarcity
Even in the present most favorable outlook, the supply of GLP-1 therapies could only cover approximately 100 million people – under 10% of those who need them, according to the health organization.
The recommendation encourages nations and manufacturers to increase access, via approaches such as licensing agreements.
Exclusive production rights on semaglutide – the main ingredient of the drug Wegovy – is due to expire in a number of nations in 2026.
How Obesity Jabs Work
The injections replicate a body's own hormone to slow digestion, curb appetite and increase the sense of being full so individuals eat less.
Individuals typically start to lose weight after several weeks of beginning the regular doses.
Studies suggests patients may regain a significant portion within a year of halting the medication, as their normal food cravings return.
Being overweight or obese increases your likelihood for experiencing health problems, including type 2 diabetes, heart disease, brain attack, and certain malignancies.
Excess weight affects individuals in all nations and was linked to millions of deaths worldwide in 2024, per the WHO.
